1:52 AM
Login form
Entries archive

My site

Main » 2024 » January » 23

LONDON - Tuesday, 23. January 2024 AETOSWire 

(BUSINESS WIRE) -- Kuwait-based low-cost airline Jazeera Airways has partnered with London headquartered Telco 1GLOBAL to become the first airline in the MENA region to launch its own travel eSIM offering. The collaboration will enable Jazeera passengers to communicate cost-effectively and avoid expensive roaming costs when travelling. At the same time, it will serve to strengthen Jazeera Airways´ customer loyalty and satisfaction, while boosting ancillary revenues.

Leveraging the power of eSIM

Through the partnership 1GLOBAL will integrate its consumer eSIM technology into Jazeera Airlines' service offering. The process will begin with the implementation of a Jazeera branded QR code and web-based solution, followed by a full-fledged integration into the Jazeera Airways app. The white label solution allows Jazeera to offer eSIM services while maintaining the airlines own look and feel.

< ... Read more »
Views: 66 | Added by: africa-live | Date: 01.23.2024 | Comments (0)

TOKYO - Tuesday, 23. January 2024 AETOSWire 

The museum also ranked number one in Honichi Lab’s 'Popular Inbound Tourist Destinations Ranking'.

(BUSINESS WIRE) -- teamLab Planets TOKYO DMM in Toyosu (teamLab Planets) ranked in the top 5 of the 'Most Popular Museums in the World' (*1) in Google’s 'Year in Search 2023' annual search ranking. This ranking lists the museums that were most searched on Google Maps globally in 2023. teamLab Planets is the only museum in Japan, and among renowned museums and art galleries with histories spanning over a hundred years.

Google Maps: Top Museums

Louvre Museum, Paris, France

The British Museum, London, United Kingdom

Musée d'Orsay, Paris, France

Natural History Museum, London, United Kingdom

teamLab Planets, Tokyo, Japan

Rijksmuseum, Amsterdam, Netherlands

Prado National Museum, Madrid, Spain

Van Gogh Museum ... Read more »

Views: 51 | Added by: africa-live | Date: 01.23.2024 | Comments (0)

Not intended for UK-, US- or Canada-based media

Abstracts to be presented at the 2024 American Society of Clinical Oncology’s annual Genitourinary Cancers Symposium provide insights into treatment selection and sequencing, as well as quality of life
Latest real-world data show median overall survival (OS) from start of first-line chemotherapy of about 30 months for patients treated with the JAVELIN Bladder regimen without progression following chemotherapy
Exploratory analyses suggest that in patients who received ADC therapy after the JAVELIN Bladder regimen, median OS from start of first-line chemotherapy reached 40 months in real-world study
(BUSINESS WIRE)--Merck, a leading science and technology company, today announced new real-world data that continue to reinforce the JAVELIN Bladder regimen of first-line platinum-based chemotherapy followed by BAVENCIO® (avelumab) maintenance as a standard of care for eligibl ... Read more »

Views: 54 | Added by: africa-live | Date: 01.23.2024 | Comments (0)

TOKYO - Tuesday, 23. January 2024

(BUSINESS WIRE) -- The Japan Prize Foundation announced the winners of the 2024 Japan prize at 1PM today, 23 January, 2024. Prof. Sir Brian J. Hoskins (UK) and Prof. John Michael Wallace (USA) are co-winners of the Japan Prize in the fields of Resources, Energy, the Environment, and Social Infrastructure, and Prof. Ronald M. Evans (USA) has been awarded the Japan Prize in the fields of Medical Science and Pharmaceutical Science.

For this year’s Japan Prize, Prof. Hoskins and Prof. Wallace are being recognized for their distinguished contributions to Establishment of a scientific foundation for understanding and predicting extreme weather events, and Prof. Evans is being recognized for his Discovery of the nuclear hormone receptor family and its application to drug development.

For the 2024 Japan Prize, the Foundation asked approximately 15,500 prominent scientists and engineers from around the world to nominate research ... Read more »

Views: 63 | Added by: africa-live | Date: 01.23.2024 | Comments (0)

 Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that Activ Surgical, a digital surgery pioneer and a portfolio company of Hikma Ventures – the strategic venture capital arm of Hikma Pharmaceuticals PLC, has announced that it has completed its first international surgery using its ActivSight™ Intelligent Light (ActivSight) at Abdali Hospital, a member of the Clemenceau Network, in Amman, Jordan.

The ActivSight technology aims to provide advanced visualization in real-time, and on-demand surgical insights in the operating room. ActivSight is an easy-to-adapt module that seamlessly attaches to today’s lapar ... Read more »

Views: 56 | Added by: africa-live | Date: 01.23.2024 | Comments (0)


A high-level delegation from the Kingdom of Saudi Arabia has concluded its participation in the World Economic Forum (WEF) Annual Meeting 2024, culminating in an announcement that Riyadh will host a WEF Special Meeting on global cooperation, growth and energy, between 28-29 April 2024.

From 15-19 January, the Saudi delegation, Chaired by His Highness Prince Faisal bin Farhan bin Abdullah, Minister of Foreign Affairs, participated in critical dialogues, bilateral and multilateral meetings to shape solutions to global challenges, to build the foundations for a more connected, resilient and thriving future.
The delegation included Her Royal Highness Princess Reema bint Bandar AlSaud, Ambassador ... Read more »

Views: 41 | Added by: africa-live | Date: 01.23.2024 | Comments (0)

ZUG, Switzerland - Monday, 22. January 2024

    Restylane® SHAYPE™ is the firmest hyaluronic acid (HA) injectable available,1,2* designed for deep injection onto bone2 and providing a bone-mimicking effect to shape the lower face
    Powered by new NASHA HD™ technology, Restylane® SHAYPE™ is the latest addition to the Restylane® portfolio, the world’s most diverse range of HA fillers


(BUSINESS WIRE) -- Galderma, the emerging pure-play dermatology category leader, announced today it has received approval from Health Canada for Restylane® SHAYPE™, a hyaluronic acid (HA) injectable designed for temporary augmentation of the chin region.2 Engineered to build and shape on bone with deep injection for a bone-mimicking effect,1,2,3,4† Restylane® SHAYPE™ will be available in Canada as of February 2024.

The chin is a critical component of overall ap ... Read more »

Views: 43 | Added by: africa-live | Date: 01.23.2024 | Comments (0)